Bioage Labs Stock Alpha and Beta Analysis
| BIOA Stock | 18.81 0.09 0.48% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioAge Labs. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioAge Labs over a specified time horizon. Remember, high BioAge Labs' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioAge Labs' market risk premium analysis include:
Beta 0.19 | Alpha 2.14 | Risk 6.44 | Sharpe Ratio 0.25 | Expected Return 1.62 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out BioAge Labs Backtesting, BioAge Labs Valuation, BioAge Labs Correlation, BioAge Labs Hype Analysis, BioAge Labs Volatility, BioAge Labs History and analyze BioAge Labs Performance. BioAge Labs Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioAge Labs market risk premium is the additional return an investor will receive from holding BioAge Labs long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioAge Labs. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioAge Labs' performance over market.| α | 2.14 | β | 0.19 |
BioAge Labs expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BioAge Labs' Buy-and-hold return. Our buy-and-hold chart shows how BioAge Labs performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.BioAge Labs Market Price Analysis
Market price analysis indicators help investors to evaluate how BioAge Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioAge Labs shares will generate the highest return on investment. By understating and applying BioAge Labs stock market price indicators, traders can identify BioAge Labs position entry and exit signals to maximize returns.
BioAge Labs Return and Market Media
The median price of BioAge Labs for the period between Tue, Oct 28, 2025 and Mon, Jan 26, 2026 is 11.61 with a coefficient of variation of 37.95. The daily time series for the period is distributed with a sample standard deviation of 4.38, arithmetic mean of 11.53, and mean deviation of 3.57. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | BioAge Labs GAAP EPS of -0.56 misses by 0.07 | 11/07/2025 |
2 | Disposition of 20000 shares by Ashworth Andrew P. of BioAge Labs, at 7.05 subject to Rule 16b-3 | 11/28/2025 |
3 | Disposition of 18000 shares by Rubin Paul D of BioAge Labs, at 12.0 subject to Rule 16b-3 | 12/09/2025 |
4 | Paul Rubin Sells 18,000 Shares of BioAge Labs Stock - MarketBeat | 12/12/2025 |
5 | BioAge Labs Hits New 1-Year High Time to Buy | 12/24/2025 |
6 | Disposition of 7433 shares by Rubin Paul D of BioAge Labs at 12.8468 subject to Rule 16b-3 | 01/02/2026 |
7 | BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP ... | 01/12/2026 |
8 | Disposition of 8974 shares by Goldstein Dov A Md of BioAge Labs at 18.4278 subject to Rule 16b-3 | 01/15/2026 |
9 | BioAge Labs plans up to 75M public stock offering shares down | 01/20/2026 |
10 | BioAge Announces Pricing of Upsized 115.0 Million Public Offering | 01/22/2026 |
About BioAge Labs Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioAge or other stocks. Alpha measures the amount that position in BioAge Labs has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
BioAge Labs Investors Sentiment
The influence of BioAge Labs' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BioAge. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to BioAge Labs' public news can be used to forecast risks associated with an investment in BioAge. The trend in average sentiment can be used to explain how an investor holding BioAge can time the market purely based on public headlines and social activities around BioAge Labs. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
BioAge Labs' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BioAge Labs' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average BioAge Labs' news discussions. The higher the estimated score, the more favorable is the investor's outlook on BioAge Labs.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioAge Labs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioAge Labs' short interest history, or implied volatility extrapolated from BioAge Labs options trading.
Build Portfolio with BioAge Labs
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out BioAge Labs Backtesting, BioAge Labs Valuation, BioAge Labs Correlation, BioAge Labs Hype Analysis, BioAge Labs Volatility, BioAge Labs History and analyze BioAge Labs Performance. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
BioAge Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.